Genomic and Biological Analysis of the Mechanism Underlying Dibifree® Dietary Supplement

The mechanistic study employed NGS-RNAseq to capture differential gene expressions, which were subsequently analyzed using big data analysis, the GSEA predictions revealed that Dibifree® reversed the pathological kidney gene pattern observed in patients with type 2 diabetes. The network diagram derived from comprehensive databases (KEGG, GO, and DO) depicted the correlations between Dibifree® and diabetes, including diabetes-related comorbidities. Examination of 2 different concentrations of Dibifree in BEAS-2B cells. *************************************************************** Submitter states that missing raw files are due to file loss. ***************************************************************